Variant report
Variant | esv3387667 |
---|---|
Chromosome Location | chr18:28026154-28030152 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr18:28013859..28016502-chr18:28028826..28031550,2 | K562 | blood: | |
2 | chr18:28024534..28026953-chr18:28028967..28030712,2 | K562 | blood: | |
3 | chr18:28024534..28026953-chr18:28028967..28030712,2 | K562 | blood: | |
4 | chr18:28018586..28020882-chr18:28024384..28026513,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188374610 | chr18:28026803-28026804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs1899535 | chr18:28026806-28026807 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs533947453 | chr18:28026816-28026817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs1899536 | chr18:28026898-28026899 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
5 | rs570977570 | chr18:28026904-28026905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs59606645 | chr18:28026924-28026925 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs556677421 | chr18:28026944-28026945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs374244349 | chr18:28026945-28026946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs8086427 | chr18:28026952-28026953 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs143618814 | chr18:28026966-28026967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs4101121 | chr18:28026972-28026973 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs573617807 | chr18:28026974-28026975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs572666180 | chr18:28027015-28027016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs16948070 | chr18:28027026-28027027 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs560518790 | chr18:28027078-28027079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs563768758 | chr18:28027091-28027092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs61391012 | chr18:28027095-28027096 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs543155999 | chr18:28027113-28027114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs561446634 | chr18:28027116-28027117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs529083720 | chr18:28027134-28027135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs547526782 | chr18:28027156-28027157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs372794452 | chr18:28027159-28027160 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs180741464 | chr18:28027216-28027217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs376001760 | chr18:28027240-28027241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs1442983 | chr18:28027265-28027266 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs570891785 | chr18:28027318-28027319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs186022722 | chr18:28027320-28027321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs7231669 | chr18:28027322-28027323 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
29 | rs550344429 | chr18:28027343-28027344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs372986748 | chr18:28027396-28027397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs80167005 | chr18:28027503-28027504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs148298660 | chr18:28027551-28027552 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs9961962 | chr18:28027564-28027565 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs189716306 | chr18:28027579-28027580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs572527786 | chr18:28027660-28027661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs369260473 | chr18:28027707-28027708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs563941154 | chr18:28027710-28027711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs75678807 | chr18:28027765-28027766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs575681531 | chr18:28027772-28027773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs368812130 | chr18:28027831-28027832 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542970474 | chr18:28027832-28027833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs62079990 | chr18:28027862-28027863 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs573643527 | chr18:28027881-28027882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs540888790 | chr18:28027916-28027917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs559524724 | chr18:28027941-28027942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs561198834 | chr18:28027996-28027997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs533144332 | chr18:28028018-28028019 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs140469274 | chr18:28028037-28028038 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs12605225 | chr18:28028115-28028116 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs181370188 | chr18:28028128-28028129 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 18350619 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Trisomy 18 syndrome | 17576883 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Multiple myeloma | 17550852 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
18q deletion syndrome | 19533772 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Colorectal cancer | 21102417 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Pancreatic cancer | 21811562 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Mucosa-associated lymphoid tissue lymphomas | 21459788 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21785460 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Prostate cancer | 16573809 | CNVD |
Autism | 16446308 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17133270 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17603634 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Renal cell carcinoma | 19150565 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Colorectal cancer | 19150955 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Breast cancer | 22737080 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr18:28026800-28027600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr18:28026800-28027800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr18:28026800-28027800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr18:28026800-28028200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr18:28027400-28027800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
6 | chr18:28027400-28028000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr18:28028000-28029000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr18:28029200-28029800 | Enhancers | Placenta Amnion | Placenta Amnion |
9 | chr18:28029800-28030800 | Weak transcription | Placenta Amnion | Placenta Amnion |